2020 W Harrison St, Chicago, IL 60612

call: (312) 572-4716
text: (872) 256-3404

Participate!

Why PrEP?​​

Over the past two decades, HIV rates have fallen drastically across the U.S.  In the last few years, however, infection rates among young men and trans women who have sex with men have been increasing. The CDC reported that these rates increased to the point that these populations made up more than 65% of all new infections in 2011. 

PrEP is a drug that, when taken daily, can give protection against HIV. The CDC states that daily PrEP reduces the risk of getting HIV from sex by more than 90%.

WHY THIS STUDY?

The Facts:

Our Goals:

PrEP is a taken daily, and is only effective when patients take it consistently (more than 4 times a week).  Studies have found that PrEP-users 18 to 24 years of age were substantially less consistent in taking the medication than those 30 and older (Grant, 2014). 
To determine if young men and trans women can benefit from systems that allow PrEP users to track their own habits and protection levels. Can we use this technology to help stop HIV in its tracks?